Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Journal of Gastroenterology|April 29, 2011
EUS-FNA for suspected malignant biliary strictures after negative endoscopic transpapillary brush cytology and forceps biopsyYasuhiro Ohshima, Ichiro Yasuda, Hiroshi Kawakami, et al.
Annals of Nuclear Medicine|January 23, 2013
Biological evaluation of 3-[(18)F]fluoro-α-methyl-D-tyrosine (D-[(18)F]FAMT) as a novel amino acid tracer for positron emission tomographyYasuhiro Ohshima, Hirofumi Hanaoka, Hideyuki Tominaga, et al.
Annals of Nuclear Medicine|November 22, 2020
Absorbed dose simulation of meta-211At-astato-benzylguanidine using pharmacokinetics of 131I-MIBG and a novel dose conversion method, RAPTetsuya Sakashita, Shigeki Watanabe, Hirofumi Hanaoka, et al.
Bioorganic & Medicinal Chemistry|July 8, 2022
Copper-mediated radioiodination and radiobromination via aryl boronic precursor and its application to 125I/77Br-labeled prostate-specific membrane antigen imaging probesYuto Kondo, Hiroyuki Kimura, Ichiro Sasaki, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 20, 2018
Antitumor effects of radionuclide treatment using α-emitting meta-211At-astato-benzylguanidine in a PC12 pheochromocytoma modelYasuhiro Ohshima, Hitomi Sudo, Shigeki Watanabe, et al.
The Journal of Chemical Physics|December 17, 2009
Vibrational and rotational structure and excited-state dynamics of pyreneMasaaki Baba, Motohisa Saitoh, Yasuyuki Kowaka, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 28, 2015
Development of a Widely Usable Amino Acid Tracer: ⁷⁶Br-α-Methyl-Phenylalanine for Tumor PET ImagingHirofumi Hanaoka, Yasuhiro Ohshima, Yurika Suzuki, et al.
EJNMMI Physics|December 13, 2021
Nonclinical study and applicability of the absorbed dose conversion method with a single biodistribution measurement for targeted alpha-nuclide therapyTetsuya Sakashita, Shojiro Matsumoto, Shigeki Watanabe, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 19, 2025
An 211At-labeled alpha-melanocyte stimulating hormone peptide analog for targeted alpha therapy of metastatic melanomaHiroyuki Suzuki, Saki Yamashita, Shoko Tanaka, et al.
Cancer Science|July 29, 2016
Efficacy of system l amino acid transporter 1 inhibition as a therapeutic target in esophageal squamous cell carcinomaYasuhiro Ohshima, Kyoichi Kaira, Aiko Yamaguchi, et al.
Pageof 8